Antivirals Flashcards
Classes of Antivirals
– Hepatitis inhibitors
– Non‐nucleoside reverse transcriptase inhibitors
– HIV protease inhibitors
– Fusion/Entry
– Integration inhibitors.
Antiherpes/CMV Drug list
- Acyclovir
- Ganciclovir
- Foscarnet
Antihepatitis Drug List
- Interferons
- Ribavirin
- Simepravir
- Sofosbuvir
- Ledipasvir/Sofosbuvir
Anti-influenza
• Amantidine, Oseltamivir, Zanamivir
Inhibition of Viral DNA polymerase
- acyclovir
- vidarabine
- foscarent
- ganciclovir

DNA structure
base + sugar = nucleoside
base + sugar + phosphate = nucleotide
Herpes simplex virus agens
Acyclovir
*guanosine look alike
Antiherpes MOA
Hase to undergo 3 phosphorylations . . .
inhibits polymerization and causes chain termination.
Competes with deoxyGTP and competitively inhibits viral DNA polymerase, therefore no DNA synthesis.

What is the first step for the MOA of Acyclovir?
Metabolically activated via 3 phosphorylations. Initial
phosphorylation occurs by viral thymidine kinase

Acyclovir ADME
– May be administered topically and via i.v.
(unique to acyclovir)
– Diffuses into most tissues/body fluids including CSF
The earlier in the infection that you take it, the better.
Acyclovir is a first-line agent against:
Herpes simplex encephalitis
neonatal HSV
severe HSV or
VZV infections
Main acyclovir TOXICITIES
neuro and renal toxicity
Acyclovir mechanism of resistance
Alteration (mutation) in viral thymidine kinase or viral _DNA
polymerase_ (Primary mechanism)
– Cross resistant to valacyclovir, famciclovir, ganciclovir
Acyclovir resistance can be treated with:
Foscarnet (doesn’t require viral phosphorylation)
Anti CMV agents
- Ganciclovir
- Foscarnet
Ganciclovir MOA
Acyclic guanosine analog (requires tri‐phosphorylation similar to acyclovir), first phosphorylation cataylzed by CMV kinase
Active against: CMV (100x > acyclovir)
What is the main toxicity of Ganciclovir?
Myelosuppression
When is the treatment of CMV related to transplant?
Used as treatment/prophylaxis for CMV post‐transplantation
Foscarnet MOA
Inhibits Viral DNA polymerase, RNA polymerase, HIV RT. No activation required!!!!
Looks like phosphate
Useful in strains resistant to acyclovir
Foscarnet Administration
IV only!!!!
Foscarnet TOXICITIES
- Renal toxicity
- Hyperphosphatemia, hypokalemia/calcemia/magnesemia
AntiHepatitis Agents
- *Ribavarin**
- *Pegylated (Peg) Interferon**
HCV Protease Inhibitors **not HIV*
Simeprevir (Olysio)
HCV Polymerase Inhibitors
Sofosbuvir (Solvadi)
Sofosbuvir/Ledipasvir (Harvoni)
How do the interferons work?
Pegylated forms = LONG half lives! (once per week injection)
antiviral
immunomodulatory (boosts immunity)
antiproliferative actions
How does INterferon work?
Interferon alpha
_ Induces_ intracellular signals leading to _inhibition of viral
penetration/translation/transcription/protein
processing/maturation_, and release
↑ major histocompatibility complex antigens
↑ phagocytic activity of macrophages
↑ the proliferation and survival of cytotoxic T cells.
Has direct effect on virus as well
What are the toxicities of alpha interferon?
“flu-like symptoms”
= biggest downfall
abortifacent
Ribavirin (HCV)
Guanosine analog that is phosphorylated intracellularly . Blocks capping of viral mRNA _inhibits viral RNA‐dependent
polymerase_
*Can be used in combination with interferon
Ribavarin (HCV) Toxicities
Hemolytic anemia
teratogenic
How is Simeprevir used?
Oral use in **_combination w/peginterferon alfa and ribavirin to treat HCV_** genotype 1 (Standard of care, 24‐48 weeks)
Simeprevir MOA
Protease inhibitor: Targets NS3/4A protease
Simeprevir toxicities
P‐glycoprotein transporter/CYP3A4 inhibitors/substrates =
Rx‐Rx interactions (rosuvastatin/atorvastatin)
What is the most effective drug for HCV?
Sofosbuvir
Sofosbuvir MOA
RNA‐dependent NS5B RNA Polymerase inhibitor.
What’s special about Sofosbuvir?
Activity against all HCV genotypes (1‐6) AND those resistant to PIs. Use in combo with w/peginterferon alfa and ribavirin
What are Sofosbuvir Toxicities?
P‐glycoprotein transporter substrate, contraindicated with P‐gp inducers (rifampin). $1,000 per pill!!!!!!
Ledipsavir/Sofosbuvir
Inhibits NS5A protein which impacts replication (interacts with NS5B), assembly, release and host cell function
Ledipsavir/Sofosbuvir Effectiveness
Activity against all HCV genotypes (1‐6) AND those resistant to PIs. 99% SVR!! FDA approved combo without peg or ribavarin.
When do you give anti-influenza agents?
Quicly, withing 48 hrs of onset of symptoms
How do Tamiflu and Relenza work?
Oseltamivir (Tamiflu,oral) and zanamivir (Relenza, inhalation)
– Neuraminidase inhibitors: Analogs of sialic acid = inhibit release
Tamiflu and Relenza Targets
Activity against influenza A and B. Zanamivir is useful against oseltamivir‐resistant strains

Anti-retroviral
Non-Nucleoside/Nucleotide RTI
- Abacavir
- Tenofovir
- Lamivudine/Emtricitibine
- Efavirenz
Don’t wanna b LATE!!
Antiretroviral
HIV protease inhibitors
- Ritonavir
- Darunavir
- Atazanavir
Antiretroviral
Fusion, entry, and integration inhibitors
- Enfuvirtide
- Maraviroc
- Dolutegravir
How do proviruses enter a cell?
- Bind to **CD4/Chemokine **receptors
- Fuse with cell, uncoating
-
Synthesize dsDNA copy of
ssRNA genome by RT - Translocate to nucleus
- Integrate into DNA
- Transcribe/Translate viral
proteins (by cell) - Assemble new virions
= Proteolytically “mature” virus
Why are retroviruses prone to resistance?
Retroviral replication ERROR PRONE = Increased mutation frequency
What is Cobicistat used for?
CYP3A4 inhibitor therefore increases bioavailability of other drugs
Combo THERAPY
Standard of care. Drugs are selected based on patient’s strain resistance: Genotype strain for mutations in RT and protease genes.
Nucleoside reverse transcriptase inhibitors
(NRTIs)
Competitive inhibition of RT
– Incorporation into viral DNA. Activated by cellular phosphorylation to triphosphate
Why is there usually resistance to NRTIS?
Mutations in viral RT
What is an example of NRTIs?
Zidovudine/AZT

NRTI Toxicity
_ Lactic acidosis w/hepatic steatosis_ – life‐
threatening
– Due to NRTI‐mediated inhibition of mitochondrial function **Build‐up of triglycerides = hepatic steatosis
Abacavir Toxicities
Myocardial infarction
_Hypersensitivity reactions _
Who should not receive Abacavir?
_Individuals with HLA‐B*5701_ or a reaction should NEVER receive abacavir!!!!
Lamivudine & Emtricitabine
Used in HBV treatment (inhibits HBV RT)
Emtricitabine = fluorinated analog of lamivudine = long t½
= once‐daily dosing
Tenofovir
nucleotide analog of adenosine. Competitively inhibits HIV RT = chain termination after incorporation into DNA
How is Tenofivir Administered?
Tenofovir is co‐administered with emtricitabine as a first‐line
RTI backbone therapy
Tenofivir Toxicity
Renal Accumulation: Tubular necrosis, Renal failure, Fanconi’s
Syndrome
Non‐nucleoside Reverse Transcriptase Inhibitors
(NNRTIs)
Efavirenz
Bind directly to HIV‐1 reverse transcriptase and inhibit RNA‐ and DNA‐dependent DNA polymerase activity
• Binding site of NNRTIs is distinct from that of NRTIs (allosteric)
DDIs with NNRTs!
Extensive metabolism/induction via P450 (CYP3A4) pathway = drug‐drug interactions (limits use in HAART)
Efavirenz
Half life is DAYS!!!
Toxicity: Nightmares/Psychiatric disturbances (at start
of therapy, then resolve)
HIV protease inhibitors
Pepitdomimetics. Metabolized by, inhibitors of CYP3A4 (drug interactions)

HIV protease inhibitors TOXICITIES
– Lipodystrophy
– ↑ triglycerides/LDL
PI: Ritonavir
Inhibitor of CYP3A4 =
used with other PIs to ↑
their serum levels= less
frequent dosing, more
tolerability (“BOOSTING”)
↑ triglycerides/LDL, elevated serum
aminotransferase
levels
Atazanavir
Concurrent use with antacids block absorption
Darunavir
Don’t give with sulfa allergy!!!
Lopinavir
Only available as a fixed dose combo w/ritonavir
ritonavir Inhibits CYP3A4 = ↑ lopinavir blood levels
Entry Inhibitors
Maraviroc: Binds selectively to CCR5
When is Maraviroc used?
Used in HIV‐1 strains resistant to other drugs
Enfuvirtide
Binds to gp41 s
– Sub‐cutaneous injection (peptide)
Only for treatment experienced HIV patients
w/ongoing HIV replication
Integrase Strand TransferInhibitors (INSTIs)
“gravir”
Dolutegravir: Inhibits viral DNA strand integration in host genome
*effective in INSTI resistance
Treatment Targets
